Moderna 5. Mai 2026 Boston biotech firms back new effort to preserve U.S. edge in life sciences - The Business Journals
Moderna 4. Mai 2026 Vertex drops Moderna-partnered inhaled cystic fibrosis candidate after unresolved tolerability issues - Fierce Biotech
Moderna 4. Mai 2026 Biopharma bites: Tolerability sinks Vertex-Moderna's CF candidate, Takeda's immune win, and more from Amgen, Latus - FirstWord Pharma
Moderna 1. Mai 2026 Moderna sees revenue bump from international COVID vaccine sales - BioPharma Dive
Moderna 30. Apr. 2026 Moderna loses key mRNA patent in European vaccine fight - Life Sciences Intellectual Property Review
Moderna 28. Apr. 2026 Moderna Deploys Salesforce Agentforce Life Sciences to Unify Global Commercial Operations - HIT Consultant
Moderna 28. Apr. 2026 CureVac targets Moderna with 10-patent suit over Spikevax - Life Sciences Intellectual Property Review
Moderna 22. Apr. 2026 Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial - BioPharma Dive
Moderna 22. Apr. 2026 Moderna launches mRNA bird flu vaccine trial after HHS cancels funding - The Washington Post
Moderna 21. Apr. 2026 Moderna | History, Innovation, Challenges, & Facts | Britannica Money - Britannica
PharmaVoice 31. März 2026 mRNA is poised to rise beyond infectious diseases, if it’s not derailed by R&D cuts
eLife 23. März 2026 Dynamic regulation of mRNA acetylation at synapses by spatial memory in mouse hippocampus
eLife 20. März 2026 Competition for the conserved branch point sequence influences physiological outcomes in pre-mRNA splicing